COVID-19 infection and hospitalization rates have been significantly higher among unvaccinated people during the recent omicron wave compared to rates among those who are fully vaccinated or boosted, a Feb. 1 CDC report found.
Patient Safety & Outcomes
The National Institutes of Health has started a study to test whether a temporary reduction in immunosuppressive medication among organ transplant recipients leads to a better antibody response to COVID-19 vaccination.
Hospitalized COVID-19 patients who received a combination of remdesivir and hyperimmune intravenous immunoglobulin — a highly concentrated solution of antibodies that neutralize SARS-CoV-2 — did not fare better than those who received remdesivir alone, according to phase 3 trial results…
A third dose of Pfizer or Moderna's COVID-19 vaccine reduces the risk of hospitalization among people with weakened immune systems, according to a CDC report published the week of Jan. 28.
A year after COVID-19 patients left intensive care, almost 75 percent reported lingering physical symptoms, more than 26 percent reported mental symptoms and more than 16 percent had cognitive symptoms, according to a study published Jan. 24 by JAMA Network.
Advertisement
Surgical patients treated in hospitals with good work environments for nurses are less likely to require intensive care or die, according to a study published Dec. 15 in AACN Advanced Critical Care.
While the highly transmissible omicron variant has pushed U.S. cases and hospitalizations to record highs, a smaller proportion of cases resulted in hospitalization compared to earlier pandemic surges, according to the CDC's Jan. 25 Morbidity and Mortality Weekly Report.
Clinicians may be able to determine which patients are at risk of developing prolonged COVID-19 symptoms based on four clinical factors measured at the time of diagnosis, according to a study published Jan. 24 in Cell.
Children's hospitals nationwide have seen record levels of COVID-19 patients amid the omicron surge, despite children having the lowest risk of hospitalization from the virus.
In a small study of 100 people who contracted COVID-19 in the first wave, more than half have long-term changes to their sense of smell, according to preliminary research published Jan. 20 by MedRxiv.